PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1992 August; 85(8): 508.
PMCID: PMC1293614

Breast cancer and liver metastases--incidence, diagnosis and outcome.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (229K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • O'Reilly SM, Richards MA, Rubens RD. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer. 1990;26(5):574–577. [PubMed]
  • O'Reilly SM, Coleman RE, Rubens RD. Phase II study of mitoxantrone for liver metastases from breast cancer. Cancer Chemother Pharmacol. 1989;25(1):73–74. [PubMed]
  • Twelves CJ, O'Reilly SM, Coleman RE, Richards MA, Rubens RD. Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry. Br J Cancer. 1989 Dec;60(6):938–941. [PMC free article] [PubMed]
  • Twelves CJ, Richards MA, Smith P, Rubens RD. Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: initial weekly treatment followed by rescheduling and intensification. Ann Oncol. 1991 Oct;2(9):663–666. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press